• Remote Screening for Asymptomatic Atrial Fibrillation
        JAMA, Published Online: August29,2025,doi: 10.1001/jama.2025.15440
        Click to Read the Study

        Importance  Screening for atrial fibrillation (AF) might reduce stroke if it increases long-term AF detection and anticoagulation use compared with usual care.

      • Long‐Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries

        https://www.ahajournals.org/doi/10.1161/JAHA.124.039780 8/6/2025 Journal of American Heart Association

      • Warning: Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban 4/15/2024 JAMA

            • Question:Do patients with atrial fibrillation receiving apixaban or rivaroxaban and concurrently treated for ventricular rate control with diltiazem have greater risk of serious bleeding than those treated with metoprolol?

            • Findings: In this cohort study of 204 155 patients aged 65 years or older, those treated with diltiazem had a significantly greater risk of serious bleeding compared with those treated with metoprolol.

            • Meaning: Among older adults with atrial fibrillation receiving apixaban or rivaroxaban, treatment with diltiazem was associated with increased risk of serious bleeding compared with metoprolol.